Nutex Health Inc. held its annual stockholders meeting on July 14, 2025. During the meeting, all seven director nominees were elected. An amendment to the Amended and Restated Nutex Health Inc. 2023 Equity Incentive Plan was approved, increasing the number of shares available for issuance and allowing for an automatic annual increase. Grant Thornton LLP was ratified as the independent registered public accounting firm for the year ending December 31, 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nutex Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-25-035002), on July 16, 2025, and is solely responsible for the information contained therein.